Stay updated on Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.

Latest updates to the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check19 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial involving nab-paclitaxel and gemcitabine for pancreatic cancer, while adding a new version number and some terminology related to pancreatic diseases.SummaryDifference11%
- Check27 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.1 to version 2.14.2.SummaryDifference0.0%
- Check111 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check120 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
Stay in the know with updates to Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Gemcitabine vs Gemcitabine Alone Clinical Trial page.